Canopy Growth Reports Earnings After Restating Two Years, But the Numbers Were Never the Issue

Canopy Growth Corporation (CGC) reports fiscal Q4 2026 earnings before the open on June 15, 2026, with analysts expecting a loss of $0.06 per share. The cannabis producer faces a critical test as it attempts to demonstrate meaningful progress toward profitability after a volatile year marked by massive losses and recent operational improvements. With the stock trading at $1.00 and technical indicators flashing warning signs across all timeframes, investors will scrutinize whether management can sustain the momentum from last quarter's surprise beat.

Part 1: Earnings Preview

Canopy Growth Corporation is a Canadian cannabis company operating across cultivation, production, and distribution of medical and recreational cannabis products. The company has struggled with profitability as it navigates a challenging regulatory environment and competitive pressures in both domestic and international markets.

Canopy Growth is scheduled to report fiscal Q4 2026 results before the market opens on June 15, 2026. Analysts expect an EPS loss of $0.06 on consensus revenue estimates around $75.93 million. The company most recently reported Q3 2026 results on February 6, 2026, posting an EPS loss of $0.10, which badly missed the consensus estimate of -$0.03 by 233%. Year-over-year, the expected Q4 loss of $0.06 represents a 93.62% improvement compared to the devastating $0.94 loss reported in Q4 2025, suggesting the company has made substantial progress in cost reduction and operational efficiency.

Three key themes define this earnings story:

Financial Restatement and Reporting Integrity: Canopy Growth announced on May 15, 2026 that it will file restated financial results for fiscal years 2025 and 2024 alongside its Q4 2026 results. This refiling raises questions about accounting practices and internal controls, adding uncertainty to an already challenging investment thesis. Investors will scrutinize management's explanation and assess whether the restatements materially alter the company's historical performance trajectory.

Path to Profitability: After years of heavy losses, the dramatic year-over-year improvement in expected EPS suggests Canopy Growth may finally be turning a corner. The company has undergone significant restructuring, and analysts are projecting continued improvement with next quarter's estimate of just -$0.01 and fiscal 2027 expectations of -$0.11 versus -$0.36 for fiscal 2026. Whether management can demonstrate sustainable progress toward breakeven will be critical.

Revenue Growth Trajectory: Consensus revenue estimates of $75.93 million imply modest sequential decline from recent quarters but represent meaningful year-over-year growth. With the cannabis industry facing pricing pressures and market saturation in key geographies, investors will focus on whether Canopy Growth can maintain market share while improving margins.

Analyst commentary ahead of the release reflects cautious optimism tempered by significant concerns. The 7 analysts covering the stock maintain a consensus rating of 3.57 (between Hold and Buy), with 2 Strong Buy ratings and 5 Hold ratings. The mean price target of $1.74 suggests 74% upside from current levels, though the wide range between the low target of $1.02 and high target of $3.69 reflects substantial disagreement about the company's prospects. Analysts acknowledge operational improvements but remain concerned about the path to sustained profitability and the implications of the financial restatements.

Part 2: Historical Earnings Performance

Canopy Growth's recent earnings history reveals extreme volatility and a troubling pattern of significant misses interspersed with occasional beats. Over the past four quarters, the company has delivered two substantial misses and two meaningful beats, creating an unpredictable track record that has likely frustrated investors.

The most dramatic miss came in Q4 2025 (March 2025), when Canopy Growth reported a catastrophic loss of $0.94 per share against expectations of just -$0.10, representing an 840% negative surprise. This massive shortfall was followed by a modest beat in Q1 2026 (June 2025), where the company posted -$0.14 versus -$0.15 expected. The volatility continued with a strong 90.91% positive surprise in Q2 2026 (September 2025), reporting -$0.01 against -$0.11 estimates, before disappointing again in Q3 2026 (December 2025) with -$0.10 versus -$0.03 expected, a 233% miss.

The pattern suggests operational instability and difficulty in forecasting results, though the two recent beats indicate potential stabilization after the Q4 2025 disaster. The company appears to be making progress on cost control when execution is solid, but remains vulnerable to unexpected charges or operational disruptions that can dramatically swing results. Heading into Q4 2026, investors will be watching for consistency and whether management can finally deliver predictable performance.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Canopy Growth typically reports earnings before market open, meaning Day 0 represents the first full trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price behavior around Canopy Growth earnings reveals substantial volatility, with an average absolute Day 0 move of 11.81% and Day +1 move of 6.59%. The stock has demonstrated a tendency for dramatic initial reactions, with Day 0 moves ranging from a 27.34% decline (February 2025) to a 19.05% surge (August 2025).

The most recent earnings release in February 2026 produced relatively muted movement, with just a 1.85% Day 0 gain followed by a 0.91% Day 1 decline, suggesting investors may be growing numb to the company's volatile results or that expectations were already well-calibrated. However, the 13.24% average Day 0 range indicates significant intraday volatility even when the closing move is modest. Investors should prepare for potentially sharp price swings in either direction, with historical precedent for double-digit percentage moves being common rather than exceptional.

Part 2.2: Options Market Expected Move

The options market is pricing an expected move of 11.05% for the upcoming earnings release, which aligns closely with the 11.81% average historical Day 0 move. This suggests options traders are anticipating typical volatility for Canopy Growth, neither expecting an outsized reaction nor unusual calm heading into this critical report with financial restatements.

Part 3: What Analysts Are Saying

Analyst sentiment on Canopy Growth remains cautiously positioned with a consensus rating of 3.57 (between Hold and Buy), reflecting measured optimism about the company's turnaround efforts tempered by significant execution risks. The 7 analysts covering the stock include 2 Strong Buy ratings and 5 Hold ratings, with no sell-side recommendations, suggesting analysts see potential value but lack conviction for aggressive bullish calls.

The mean price target of $1.74 implies 74% upside from the current price of $1.00, though the wide dispersion between the low target of $1.02 and high target of $3.69 reveals substantial disagreement about the company's ultimate trajectory. The most bullish analysts appear to be pricing in successful execution of the turnaround and a path to profitability, while more conservative views see limited upside from current levels.

Analyst sentiment has remained unchanged over the past month, with rating counts and the average recommendation holding steady at 3.57. This stability suggests analysts are in wait-and-see mode ahead of the Q4 results and financial restatements, reluctant to adjust views until they can assess the quality of the turnaround and the impact of accounting adjustments. The consensus implies that while the risk-reward may favor patient investors willing to bet on operational improvement, the path forward remains uncertain enough to warrant a neutral-to-slightly-positive stance rather than aggressive accumulation.

Part 4: Technical Picture

Canopy Growth's technical setup heading into earnings is decidedly bearish, with the Barchart Technical Opinion showing an 88% Sell signal as of the latest reading. This represents a slight improvement from the 96% Sell signal one week ago but marks a significant deterioration from the 40% Sell signal one month ago, indicating mounting technical pressure as the stock has weakened into the earnings release.

Timeframe Analysis:

• Short-term (100% Sell): Maximum bearish signal indicates severe near-term downward momentum heading into earnings
• Medium-term (50% Sell): Moderate sell signal suggests intermediate-term weakness, though less extreme than the short-term picture
• Long-term (100% Sell): Maximum bearish reading reflects deeply entrenched weakness in the longer-term trend structure

The trend characteristics show Average strength with a Strengthening direction, suggesting the bearish momentum is building rather than exhausting, which is particularly concerning ahead of a potentially volatile earnings event.

The stock is trading at $1.00, positioned below all major moving averages: the 5-day ($1.01), 10-day ($1.03), 20-day ($1.04), 50-day ($1.09), 100-day ($1.08), and 200-day ($1.20). This complete breakdown below all moving average timeframes confirms the technical deterioration and suggests the stock has no nearby support levels. The widening gap from the 200-day moving average indicates a sustained downtrend with no signs of stabilization.

With the stock trading below all moving averages and technical indicators uniformly bearish across all timeframes, Canopy Growth enters earnings in a vulnerable technical position. The lack of nearby support and strengthening sell signals suggest any disappointment could trigger further downside, while even a positive surprise may face resistance from overhead moving averages. The technical setup is clearly cautionary, offering little cushion for investors and suggesting the bar for a sustained positive reaction is high.